4//SEC Filing
Avoro Capital Advisors LLC 4
Accession 0000902664-25-001334
CIK 0001422142other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:56 PM ET
Size
11.4 KB
Accession
0000902664-25-001334
Insider Transaction Report
Form 4
Avoro Ventures LLC
Director10% OwnerOther
Transactions
- Award
Pre-funded Warrant (right to buy)
2025-02-28$2.40/sh+8,333,000$19,998,367→ 8,333,000 total(indirect: See footnotes)Exercise: $0.00→ Common Stock (8,333,000 underlying)
Aghazadeh Behzad
Director10% OwnerOther
Transactions
- Award
Pre-funded Warrant (right to buy)
2025-02-28$2.40/sh+8,333,000$19,998,367→ 8,333,000 total(indirect: See footnotes)Exercise: $0.00→ Common Stock (8,333,000 underlying)
Avoro Capital Advisors LLC
Director10% OwnerOther
Transactions
- Award
Pre-funded Warrant (right to buy)
2025-02-28$2.40/sh+8,333,000$19,998,367→ 8,333,000 total(indirect: See footnotes)Exercise: $0.00→ Common Stock (8,333,000 underlying)
Footnotes (4)
- [F1]The securities reported herein were acquired on behalf of accounts managed by Avoro Capital Advisors and Avoro Ventures (as defined below) directly from the Issuer in a private placement.
- [F2]Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after March 4, 2025, exercise the Pre-funded Warrant until it has been exercised in full. Pursuant to the terms of the Pre-Funded Warrant, the Reporting Persons cannot exercise any of the Pre-Funded Warrants to the extent the Reporting Persons would beneficially own, after any such exercise, more than 19.99% of the outstanding Common Stock (the "19.99% Blocker"). Consequently, at this time, the Reporting Persons are not able to exercise all the Pre-Funded Warrants due to the 19.99% Blocker.
- [F3]This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures.
- [F4]The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein, if any.
Documents
Issuer
Aadi Bioscience, Inc.
CIK 0001422142
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001633313
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:56 PM ET
- Size
- 11.4 KB